Branch² Intelligence
DEFA14A - AtaiBeckley Inc. (0002081043) (Filer)
Key takeaway
Eli Lilly acquires AtaiBeckley Inc. for an undisclosed sum, gaining its mental health pipeline.
- Step 1Eli Lilly announces acquisition of AtaiBeckley Inc. for its mental health pipeline.
- Step 2Lilly integrates AtaiBeckley's R&D programs, increasing demand for contract research and manufacturing services.
- Step 3US biotech CROs and CDMOs see revenue uplift from expanded Lilly outsourcing.
Source: SEC EDGAR — Current filings
This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.